Altinmakas, Emre
Bane, Octavia
Hectors, Stefanie J.
Issa, Rayane
Carbonell, Guillermo
Abboud, Ghadi
Schiano, Thomas D.
Thung, Swan
Fischman, Aaron
Kelly, Matthew D.
Friedman, Scott L.
Kennedy, Paul
Taouli, Bachir http://orcid.org/0000-0001-6409-1333
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK113272)
Siemens USA
Perspectum
Article History
Received: 2 June 2022
Revised: 3 August 2022
Accepted: 3 August 2022
First Online: 9 September 2022
Declarations
:
: Bachir Taouli: consultancy and/or advisory roles for Bayer, Helio Health and research funding/support from Bayer, Takeda, Regeneron, Siemens Healthineers, Echosens, Stefanie Hectors: Employee of Regeneron, Matthew D. Kelly: Employee of Perspectum. The authors declare they have no non-financial interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of Mount Sinai Hospital.
: Written informed consent was obtained from all patients.